SciELO - Scientific Electronic Library Online

 
vol.26 issue3Outcomes of patients subjected to aortic valve replacement surgery using mechanical or biological prosthesesTranscatheter implantation of self-expandable valved prosthesis in outlet right ventricle an experimental study in pigs author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Cirurgia Cardiovascular

Print version ISSN 0102-7638

Abstract

GAIA, Diego Felipe et al. Transcatheter aortic valve implantation: results of the current development and implantation of a new Brazilian prosthesis. Rev Bras Cir Cardiovasc [online]. 2011, vol.26, n.3, pp. 338-347. ISSN 0102-7638.  http://dx.doi.org/10.5935/1678-9741.20110007.

OBJECTIVE: Aortic valve replacement is a routine procedure with acceptable risk, but in some cases, such risk can justify contraindication. Minimally invasive transcatheter aortic valve implantation has emerged as an alternative, with lower morbidity and mortality. The aim of this study was clinical, safety and efficacy assessment. METHODS: Thirty-three high risk patients underwent transcatheter balloon expandable aortic valve implantation. Mean Logistic EuroScore risk was 39.30% and STS score 30.28%. Eight patients presented with dysfunctional bioprosthesis, remaining ones presented calcified aortic stenosis. Procedures were performed in a hybrid OR under fluoroscopic and echocardiography guidance. Using a left minithoracotomy the prosthesis were implanted trough the ventricular apex under rapid ventricular pacing or hemorrhagic shock. Echocardiographic and angiographic controls were performed. RESULTS: Implant was feasible in 30 cases. Three conversions occured. There was only one case of operative death. Median transvalvular aortic gradient reduced from 43.58 mmHg to 10.54 mmHg. Left ventricular function improved in the first 7 postoperative days. Paravalvular aortic regurgitation was mild and present in 30.30%. One case presented major vascular complication and another one permanent pacemaker implant. One major stroke case occurred. Overall 30-day mortality was 18.18%. CONCLUSION: The transapical implantation of catheter mounted bioprosthesis is a safe procedure with acceptable midterm results. Long term follow-up with increased sample power is mandatory in order to access hemodynamic, life quality and survival

Keywords : Aortic valve; Cardiopulmonary bypass; Heart catheterization.

        · abstract in Portuguese     · text in English | Portuguese     · pdf in English | Portuguese